Cite
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review.
MLA
Fedele, Roberta, et al. “Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review.” Journal of Immunology Research, Dec. 2015, p. 968212. EBSCOhost, https://doi.org/10.1155/2015/968212.
APA
Fedele, R., Martino, M., Recchia, A. G., Irrera, G., Gentile, M., & Morabito, F. (2015). Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review. Journal of Immunology Research, 968212. https://doi.org/10.1155/2015/968212
Chicago
Fedele, Roberta, Massimo Martino, Anna Grazia Recchia, Giuseppe Irrera, Massimo Gentile, and Fortunato Morabito. 2015. “Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review.” Journal of Immunology Research, December, 968212. doi:10.1155/2015/968212.